TABLE 2.
Collection interval (h) | Mean (range) concn (μg/ml) and na for:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
FLX
|
FNO
|
NDF
|
PFL
|
NOR
|
PNO
|
|||||||
n | Concn (range) | n | Concn (range) | n | Concn (range) | n | Concn (range) | n | Concn (range) | n | Concn (range) | |
preb | 0 | -c | 0 | - | 0 | - | 0 | - | 0 | - | 0 | - |
0–6 | 12 | 217 (98–427) | 12 | 21.4 (4–70) | 12 | 16.3 (5–40) | 12 | 84.0 (37–219) | 12 | 80.3 (20–144) | 12 | 115.4 (29–233) |
6–12 | 12 | 160 (63–355) | 12 | 17.6 (4.6–62) | 12 | 16.8 (4–49) | 12 | 50.1 (22–97) | 12 | 76.3 (46.1–133) | 12 | 93.8 (19–192) |
12–24 | 12 | 102 (43–178) | 12 | 10.2 (5–19) | 12 | 12.2 (5.5–24.5) | 11d | 46.0 (8–104) | 11d | 72.9 (31–109) | 11d | 70.5 (31–115) |
24–48 | 12 | 26.8 (12–49) | 12 | 2.4 (1.2–5.8) | 12 | 3.1 (0.8–9) | 12 | 19.0 (2.3–53) | 12 | 29.1 (14–68) | 12 | 27.3 (10–70) |
48–72 | 12 | 6.3 (2.4–11.8) | 1 | 1.5e | 8 | 0.7 (0.7–1.7) | 12 | 5.8 (0.2–13.8) | 12 | 10.2 (1.7–23) | 12 | 8.7 (1.2–19) |
72–96 | 12 | 2.2 (0.8–3.9) | 0 | - | 2 | 0.2 (0.9–1.3) | 10 | 2.4 (0.3–8.9) | 12 | 3.9 (0.4–7) | 12 | 3.4 (0.2–12) |
96–120 | 8 | 0.6 (0.5–1.4) | 0 | - | 0 | - | 9 | 0.9 (0.3–3.4) | 12 | 1.5 (0.1–4.4) | 10 | 1.3 (0.1–4.2) |
120–144 | 4 | 0.3 (0.7–1) | 0 | - | 2 | 0.1 (0.6–0.8) | 8 | 0.5 (0.2–3.2) | 10 | 0.5 (0.1–2.4) | 8 | 0.5 (0.2–3.7) |
144–168 | 4 | 0.2 (0.5–0.8) | 0 | - | 1 | 0.8e | 5 | 0.2 (0.1–2) | 8 | 0.3 (0.1–2) | 6 | 0.3 (0.1–2.8) |
n, number of individuals with concentrations above the quantification limit.
pre, sample taken prior to drug administration.
-, below quantification limit.
One sample not available.
Since n = 1, the concepts of mean and range are not applicable.